PlainRecalls
FDA Drug Moderate Class II Terminated

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Reported: December 5, 2012 Initiated: October 8, 2012 #D-068-2013

Product Description

Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06

Reason for Recall

Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.

Details

Recalling Firm
GlaxoSmithKline, LLC.
Units Affected
1,319 vials
Distribution
Nationwide
Location
Zebulon, NC

Frequently Asked Questions

What product was recalled?
Arranon (nelarabine) Injection 5mg/mL, 50mL Vials, Rx only, For I.V. Infusion only, GlaxoSmith Kline, Research Triangle Park, NC 27709. Made in England, NDC 0007-4401-06. Recalled by GlaxoSmithKline, LLC.. Units affected: 1,319 vials.
Why was this product recalled?
Impurities/Degradation Products: Potential for drug related impurities to exceed the specification limits.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 5, 2012. Severity: Moderate. Recall number: D-068-2013.